• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Drug-induced autoimmune hepatitis: A minireview

    2022-07-08 03:06:04ChinKimgTanDanielleHoLaiMunWangRahulKumar
    World Journal of Gastroenterology 2022年24期

    Chin Kimg Tan, Danielle Ho,Lai Mun Wang, Rahul Kumar

    Abstract Drug-induced autoimmune hepatitis (DIAIH) is a specific phenotype of druginduced liver injury that may lead to the devastating outcome of acute liver failure requiring liver transplantation. Drugs implicated in DIAIH include antimicrobials such as nitrofurantoin and minocycline, non-steroidal anti-inflammatory drugs, statins as well as anti-tumor necrosis agents. The clinical features of druginduced liver injury are indistinguishable from idiopathic autoimmune hepatitis(AIH) as both may have positive AIH-related autoantibodies, elevated immunoglobulin G, as well as similar histopathological findings. In patients who show no clinical improvement, or there is progressive liver injury despite cessation of the suspected drug, a liver biopsy should be considered, whereby the presence of advance fibrosis on histology favors the diagnosis of idiopathic AIH. Empirical treatment with corticosteroids may be required in patients with non-resolving liver injury. A typical clinical scenario supportive of DIAIH includes a history of drug exposure with spontaneous resolution of liver injury after drug withdrawal and the absence of relapse after rapid steroid taper. In this article we report two cases of DIAIH secondary to Sorafenib and Atorvastatin along with a review of currently available literature. Early identification and treatment often lead to a favorable outcome in DIAIH.

    Key Words: Drug-induced liver injury; Drug-induced autoimmune hepatitis; Autoimmune hepatitis; Review

    INTRODUCTION

    Idiosyncratic drug-induced liver injury (DILI) is rare and affects 14-19 per 100000 persons yearly[1,2].Despite its relatively low incidence, it is a leading cause of acute liver failure in the United States[3],Europe[4,5], and Japan[6]. In patients with DILI, liver-related death and liver transplantation occur in 3.6%-10% of cases[7].

    Drug-induced autoimmune hepatitis (DIAIH) is a specific phenotype of idiosyncratic DILI with features indistinguishable from idiopathic autoimmune hepatitis (AIH), as it shares serological markers and/or histological features with idiopathic AIH[8]. Various terms have been used synonymously with DIAIH, including immune-mediated DILI[9] and drug-induced AIH-like injury[10].

    Due to its rare occurrence, it is difficult to estimate the frequency of DIAIH. In addition, studies use varying definitions of DIAIH and drug causality assessments, as well as having diverse patient populations with different follow-up periods (Tables 1 and 2). It is estimated that DIAIH accounts for 2%-18% of AIH cases[10-14], and 2.9%-8.8% of all DILI are due to DIAIH[15,16]. The increasing incidence of AIH has been in part attributed to prevalent use of anti-tumor necrosis factor agents[14].

    DRUGS ASSOCIATED WITH DIAIH

    Multiple drugs that have been associated with DIAIH are classified into those with definite association (e.g., Minocycline, Nitrofurantoin, Infliximab), probable association (e.g., Diclofenac, Atorvastatin,Rosuvastatin, Etanercept), and possible association, depending on the cases reported and associations as summarized in the most recent American Association Society of Liver Disease AIH Practice Guidance[10].

    DIAIH is classically associated with minocycline, nitrofurantoin, methyldopa, dihydralazine, and tienilic acid[17]. DILI with autoimmune phenotype defined as DILI with presence of AIH antibodies(antibodies to nuclear antigen, smooth muscle, and soluble liver antigen) occur in 83%, 74%, 60%, and 43% of nitrofurantoin, minocycline, methyldopa, and hydralazine related DILI cases, respectively[15].Immuno-allergic phenotype characterized by any combination of rash, fever, facial edema, lymphadenopathy, and eosinophilia is common in DILI associated with these four drugs as well, ranging from 11%-27%[15]. Another important cause of DIAIH include statins, where DIAIH or DILI with immune features occurs in about 8.5%-27.2% of all statin related DILI[18,19].

    In recent years, there has been a change in the predominant culprit drugs causing DIAIH to antitumor necrosis factor[14], statins, and non-steroidal anti-inflammatory drugs[16,20,21] with notable contribution from complementary alternative medicines in studies from Asia[22].

    PATHOGENESIS OF DIAIH

    Reactive metabolites generated from hepatic metabolism of drugs bind to cellular proteins such as components of CYP450, which is then recognized as neoantigens by heightened immunological response leading to AIH[11,23,24] as a result of misdirected immune response against self[25].

    In this minireview, we highlight two recent cases of DIAIH induced by Sorafenib and Atorvastatin seen at our center. We also aim to review the current literature on DIAIH and discuss distinguishing features between DIAIH and AIH.

    Table 1 Studies comparing drug-induced autoimmune hepatitis and drug-induced liver injury

    CASE DISCUSSION

    Patient A

    A 61-year-old man and teetotaler presented with a 1-week history of jaundice and malaise. He was on Atorvastatin 40 mg daily for 4 years for hyperlipidemia. He had a normal liver function test (LFT) prior to admission. He was started on Sorafenib 6 wk prior to presentation with jaundice for recurrent sarcoma of the left thigh. Clinical examination was unremarkable apart from scleral icterus. The LFT showed severe hepatocellular (HC) injury [bilirubin 4.56 mg/dL, alkaline phosphatase (ALP) 190 U/L,alanine transaminase (ALT) 1004 U/L, aspartate transaminase (AST) 790 U/L, international normalized ratio (INR) of 1.53]. Viral hepatitis screen, AIH-specific antibodies, and abdominal imaging were unremarkable. Of note, serum immunoglobulin G (IgG) was elevated (18.6 g/L). The liver biopsy showed features supportive of DILI and AIH (Figure 1). The Simplified AIH score was 6. The Roussel Uclaf Causality Assessment Model (RUCAM) score was 9 for Sorafenib and 6 for Atorvastatin.Diagnosis of Sorafenib-induced AIH was made. His LFT improved spontaneously with normalization of LFT 8 wk after stopping Sorafenib (Figure 2A).

    Patient B

    A 65-year-old man who was on Atorvastatin 40 mg daily presented with an incidental finding of acute HC pattern of liver injury 18 mo after initiation of Atorvastatin (albumin 39 g/L, globulin 39 g/L,bilirubin 0.64 mg/dL, ALP 107 IU/L, ALT 696 U/L, AST 381 U/L). Viral hepatitis screening, AIHspecific antibodies, and abdominal imaging were unremarkable. His serum IgG was normal (14.28 g/L).Atorvastatin was stopped, and an improvement in LFT was noted within the 1 wk (albumin ALT 474 U/L, AST 195 U/L). The RUCAM score for Atorvastatin was 4. As such, he was given the diagnosis of possible Atorvastatin-induced DILI. However, despite this initial improvement in his LFT, there was subsequent deterioration 2 wk after stopping Atorvastatin (albumin 34 g/L, globulin 43 g/L, ALP 137U/L, ALT 1404 U/L, AST 676 U/L, INR 1.09). A liver biopsy was performed 3 wk after stopping Atorvastatin in view of worsening acute liver injury. This showed marked HC injury with histological features suggestive of AIH (Figure 3). Following the liver biopsy, there was again spontaneous improvement (ALT 699 U/L), but this did not persist. Two months after cessation of Atorvastatin, he had severe HC injury with jaundice (bilirubin 11.87 mg/dL, ALP 96 U/L, ALT 1095 U/L, AST 938 U/L,INR 1.33) and elevated IgG (28.35 g/L). Liver biopsy was repeated, and this again demonstrated features of AIH. He was then started on prednisolone with rapid improvement of LFT (Figure 2Β). The final diagnosis was Atorvastatin-induced AIH.

    Table 2 Studies comparing drug-induced autoimmune hepatitis and autoimmune hepatitis

    WHEN TO SUSPECT DIAIH IN PATIENTS WHO PRESENTS WITH DILI

    The cases described above highlight two possible presentations of DIAIH. The first patient (patient A)had DILI and histological features compatible with AIH on liver biopsy. Although Sorafenib has not been reported to be associated with DIAIH, the temporal sequence of this case presentation and subsequent spontaneous resolution after cessation of Sorafenib is in keeping with DIAIH.

    DIAIH shares many similar characteristics with DILI without features of AIH. More than half of DIAIH present with acute liver injury associated with jaundice in 70%-75% of cases[16], which is similar to DILI. On top of that, rash may be present in 4.5% of DIAIH and 7.9% of DILI[26].

    The following pointers are useful in identification of DIAIH in patients who present with DILI. The main differences between these two conditions are also summarized in Table 3: (1) DIAIH and AIH should always be considered as differentials in a patient with a hepatocellular pattern of DILI. DIAIH is rarely associated with a cholestatic/mixed picture, and it is only seen in 8% of cases[16]; (2) A detailed medication history with a focus on recent drug exposures including complementary alternative medicines is essential[10]; (3) The latency period of drug exposure in DIAIH is usually prolonged compared to other types of DILI, some with a latency period exceeding 1 year,e.g., nitrofurantoin and minocycline[15]; (4) Seropositivity for AIH antibodies,e.g., antinuclear antibody (ANA), anti-smooth muscle antibody, anti-liver kidney antibody, and elevated serum IgG suggest possible DIAIH.However, not all patients with DIAIH have detectable autoantibodies or elevated IgG. Similarly, a proportion of patients with DILI may have detectable AIH antibodies[15,16]; (5) In the presence of detectable AIH antibodies and elevated IgG, AIH scoring (either pre-treatment score for Revised International AIH Group criteria[27] or simplified AIH score[28]) is useful to assess for possible orprobable AIH; (6) Liver-specific causality assessment tools may be used to ascertain the strength of association between drug exposure and clinical manifestation,e.g., RUCAM[29]; and (7) Liver biopsy is the cornerstone for the diagnosis of DIAIH and should be considered in the following scenarios: (a) Non resolving or worsening liver injury despite stopping possible culprit drugs; (b) Seropositivity of AIH antibodies, raised IgG, or possible AIH based on AIH scoring systems.

    Figure 1 Liver biopsy specimen for patient A. A: Low power view [hematoxylin & eosin (H&E) 100 ×] displays conspicuous portal and lobular inflammation with lobular disarray. Mild steatosis is also noted; B: Higher magnification of the portal tract (H&E 200 ×), zone 1, shows moderate chronic inflammation,lymphoplasmacytic predominantly, and rare eosinophils, with interface damage; C: At similar magnification (H&E 200 ×), the lobule including the perivenular region,e.g., zones 2 and 3, exhibits lobulitis characterized by aggregates of plasma cells, swollen hepatocytes with rosetting, Councilman bodies, and hepatocyte drop-out;D: High power view (H&E 400 ×) demonstrates rosetting of hepatocytes with droplets of orange-brown bile pigment; E and F: Histochemical stains Masson trichrome(E, 40 ×) showing collapse with mild early young fibrosis and Victoria blue (F, 40 ×) revealing paucity of elastic fibers, thus in keeping with subacute injury. Overall,the appearances are supportive of subacute drug-induced liver injury in association with autoimmune hepatitis histological pattern.

    Known culprit drugs of DIAIH such as nitrofurantoin may be overlooked as these agents are associated with longer latency period and have a lower ALT at presentation. A higher fibrosis stage or cirrhosis may be observed as a higher proportion of these patients are unknowingly continued on Nitrofurantoin prior to the diagnosis[30]. This underscores the importance of understanding the common culprits of DIAIH, where a significant proportion of DILI presents with DIAIH[15]. LiverTox?is an up-to-date online resource that provides information on hepatotoxicity caused by medications and supplements[31].

    With the increasing use of targeted tumor therapies such as kinase inhibitor and immunotherapy,there are some case reports of DIAIH associated with these medications. To our knowledge, this is the first case report of Sorafenib-induced AIH. Imatinib, another type of kinase inhibitor, has also been reported to be associated with DIAIH[14,32].

    Several studies have attempted to compare the differences between DIAIH and DILI (Table 1)[15,16,22], with key features of DIAIH including significantly longer duration of drug exposure and latency;higher ALT and AST; higher proportion of patients with positive ANA and SMA, and higher level of serum IgG, as summarized in Table 3.

    Liver biopsy is key in differentiating DIAIH from DILI without features of AIH[10,33]. In patients with DIAIH, the histopathological features are similar to that of idiopathic AIH with significantly higher proportion of patients showing severe portal inflammation, prominent portal-plasma cells, rosettes, and severe focal necrosis as compared to other types of DILI[16].

    Figure 2 Bilirubin and alanine transaminase trend for patients A and B. A: Patient A; B: Patient B.

    Though there is no significant difference in the severity and outcomes of DIAIH compared to other types of DILI, it is crucial to identify DIAIH in patients who present with DILI, as DIAIH may require treatment with immunosuppressants if liver injury does not improve with cessation of possible culprit drugs[10,31,33]. A significantly higher proportion of patients (50% to 80%) with DIAIH are treated with corticosteroids/immunosuppressants as compared to non-DIAIH DILI, and DIAIH will need longer term follow up even when LFT normalizes as late relapses may occur in up to 50% of cases where immunosuppressants are stopped[22]. Majority of relapses occur within a year, but some may present late up to 3 years after the initial diagnosis, and risk factors for late disease recurrence are not clear.

    Figure 3 Liver biopsy findings for patient B. A: Low power view [hematoxylin & eosin (H&E) 100 ×] shows portal and lobular inflammation with lobular disarray and mild steatosis; B: Higher magnification of the portal tract (H&E 200 ×) demonstrates moderate plasma cell-rich chronic inflammation with continuous interface damage; C: Lobulitis with aggregates of plasma cells and rosetting of hepatocytes is present in the lobule (H&E 200 ×); D and E: Masson trichrome (D, 40 ×)and Victoria blue (E, 40 ×) display mild early young fibrosis and paucity of elastic fibers, respectively. The absence of old mature type fibrosis suggested not a chronic injury. The autoimmune hepatitis histological pattern observed was therefore interpreted to be drug related, atorvastatin-induced.

    DIFFERENTIATING DIAIH AND IDIOPATHIC AIH

    The second case highlights the difficulty in differentiating DIAIH from idiopathic AIH. Βoth conditions have overlapping clinical presentations with HC pattern of liver injury and may have detectable ANA,SMA, and raised IgG in some cases[10,11]. A number of studies compared the difference between DIAIH and AIH (Table 2), with the key differences summarized in Table 4. Some useful features to distinguish between these two entities:

    Clinical presentation

    Majority (60%-83%) of DIAIH present with an acute presentation, whereas it is seen in less than 20%-35% of cases with idiopathic AIH[10,34]. Most studies of the two conditions do not demonstrate a significant difference in LFT levels[14,21,30,34], but ALT[13,30,34], AST[14,34], and bilirubin[14,34] tend to be higher in patients with DIAIH. Only one study[20] showed a significantly higher level of bilirubin,AST, and ALT in patients with DIAIH. There was no significant difference in the proportion of patients with detectable ANA (77-94%)[20,21] and elevated IgG (36%-59%)[14], although one study showed AIH had higher level of serum IgG compared to DIAIH; it was not, however, statistically significant[14].Immuno-allergic presentation with skin rash, fever, lymphadenopathy, and eosinophilia favor DIAIH,as it may occur in up to 30% of DIAIH[10,11].

    AIH scoring and causality assessment

    In a cohort of 44 patients with DIAIH and AIH, the simplified AIH score was not useful in differentiating the two entities[21]. Of note, patients with AIH had significantly higher pre-treatment AIH score compared to patients with DIAIH. The sensitivity and the specificity for pre-treatment AIH score (using a cut off of ≥ 12 – probable AIH) was shown to be 59% and 82%, respectively. As for RUCAM, using a cut off of ≥ 6 (probable), the specificity reaches 91%, albeit with a low sensitivity at 32%. When these are used in combination, there is still a potential for misdiagnosis in up to 11% of patients.

    Histopathology

    Βoth DIAIH and AIH share similar histological findings (portal and periportal infiltrates of lymphocytes, lobular hepatitis, plasma cells, and eosinophils) with no clear differentiating features,except presence of advance fibrosis or cirrhosis favoring idiopathic AIH[11,34]. However, a significantly higher proportion of patients with AIH showed typical features of AIH (54%) as compared to DIAIH(18.2%)[20], specifically in terms of portal inflammation with interface hepatitis and plasma cell infiltrates. The same study also found that DIAIH tended to have more eosinophilic infiltrates, which was not noted in other studies[21].

    Treatment and response to treatment

    The cornerstone in the management of DIAIH is to stop the culprit drug. Spontaneous improvement of LFT may then occur, as was observed in patient A. The most consistent and significant differentiating feature between DIAIH and AIH in published case series thus far lies in the response to treatment(Table 4). In cases where liver injury does not resolve despite cessation of the culprit drug or where the degree of DILI is severe, corticosteroids are usually started as per the initial management of AIH. Most studies on DIAIH exclusively include patients who were treated with immunosuppressants[14,20,21,30]. Βoth DIAIH and AIH showed excellent response to corticosteroids, with remission rate exceeding 90% in most cases[21,30-34].

    It should be borne in mind that there is discrepancy in literature regarding the mean time to achieve immunosuppression induced remission in DIAIH and AIH. While one study demonstrated similar 3 mo mean time to remission[21] in both conditions, another showed a significant difference, where DIAIH took a significantly shorter time than AIH to achieve remission[34] (2 movs16.8 mo). This may be attributed to the heterogeneity of the study population. Resolution of DIAIH usually occurs after 1 mo(rarely up to 3 mo) of immunosuppression. Unlike in AIH, DIAIH rarely requires long term immunosuppression and has very low relapse rates after cessation of immunosuppressants over a long follow-up of up to 4 years[10,11,13-15,20,21,34] (Table 2). In cases where DIAIH relapses, the time to relapse is significantly longer compared to AIH[30], which implies that patients with DIAIH will require a longer period of follow-up after resolution of liver injury as compared to the usual DILI. Interestingly,despite similar time to remission in the two groups, Weberet al[21] showed that an early rapid response to corticosteroid treatment differentiates DIAIH from AIH with good sensitivity and specificity at 77%,respectively. The early rapid response was defined by 9% drop of ALT per day in the first week of corticosteroid therapy.

    The use of steroids appears to be a promising means of differentiating DIAIH or AIH in the early course of disease with better sensitivity than RUCAM and AIH score[21]. This also has the potential benefit of avoiding long term immunosuppressive therapy in DIAIH. Also, in 30%-35% of DIAIH cases that were initially seropositive for ANA and SMA, the antibodies became undetectable at 6 mo following the initial DILI, which was independent of treatment with corticosteroids[15].

    Major hepatology society guidelines recommend a similar approach in terms of corticosteroids initiation in non-resolving DIAIH and AIH[10,11]. However, there is no consensus regarding treatment duration and methods to confirm remission before discontinuation of immunosuppressants. Thus, the decision and timing to stop treatment should be assessed on case-by-case basis[10]. In fact, one study has shown success in tapering off immunosuppression within 3-17 mo without evidence of relapse[20].

    Risk alleles and monocyte-derived hepatocyte like cells

    Risk alleles for idiopathic AIH such as HLA DRΒ1 DRΒ1*03:01 or DRΒ1*04:01 are uncommon in DIAIH and, if this is detected, may favor a diagnosis of AIH[10]. The MetaHeps?test, which uses monocytederived hepatocyte-like cells, has been used to differentiate DIAIH from AIH with high sensitivity and specificity[21]. However, this test is not readily available, thereby limiting its utility in clinical practice.The lymphocyte toxicity assay described by Neumanet al[35] can sometimes be helpful in differentiating drug hypersensitivity syndromes from idiopathic AIH as well.

    Outcomes

    The long-term outcome of DIAIH is excellent with a survival rate between 90%-100% without liver transplantation[10]. This is in contrast with idiopathic AIH, where there is a high risk of relapse upon treatment withdrawal and risk of progression to cirrhosis, resulting in the need for liver transplantation[10,11,34]. It is also noteworthy that DIAIH can lead to chronic DILI with abnormal LFT lasting more than 6 mo in 17%-22% of cases[15,36].

    CONCLUSION

    In summary, it is important to differentiate between DIAIH and AIH in patients who present with DILI,as the management and outcome differ. Early recognition of DIAIH is key as the mainstay of management is cessation of culprit drug and in some cases, initiation of corticosteroids with the aim to avoid long-term immunosuppression.

    ACKNOWLEDGEMENTS

    We acknowledge all our colleagues in the Department of Gastroenterology and Hepatology and Pathology at Changi General Hospital who help manage the 2 patients described in the manuscript. We would also like to thank the 2 patients described here who readily consented to be described in this manuscript.

    FOOTNOTES

    Author contributions:Kumar R and Tan CK conceptualized the study; Tan CK, Ho D, and Kumar R wrote the initial manuscript; Wand LM provided critical input and histo-pathological slides for the manuscript; all authors were involved in the critical revision.

    Conflict-of-interest statement:All authors have no relevant conflict of interest to report.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC ΒYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Singapore

    ORCID number:Chin Kimg Tan 0000-0002-3918-4340; Danielle Ho 0000-0003-0652-406x; Lai Mun Wang 0000-0001-7113-4215; Rahul Kumar 0000-0002-5092-4821.

    S-Editor:Yan JP

    L-Editor:Filipodia

    P-Editor:Yan JP

    夜夜夜夜夜久久久久| 男女下面进入的视频免费午夜| 日韩国内少妇激情av| 亚洲丝袜综合中文字幕| 日韩大尺度精品在线看网址| 日本三级黄在线观看| 亚洲av电影不卡..在线观看| 欧美成人免费av一区二区三区| 99久国产av精品| 最近2019中文字幕mv第一页| 在线免费观看不下载黄p国产| 亚洲成a人片在线一区二区| 国产探花在线观看一区二区| 欧美日韩一区二区视频在线观看视频在线 | 91狼人影院| 22中文网久久字幕| 丰满的人妻完整版| 亚洲五月天丁香| 欧美3d第一页| 内射极品少妇av片p| 国产三级中文精品| 成人特级av手机在线观看| 在现免费观看毛片| 免费观看精品视频网站| 在线观看av片永久免费下载| 综合色av麻豆| 51国产日韩欧美| 啦啦啦观看免费观看视频高清| 插逼视频在线观看| 国产成年人精品一区二区| 一区二区三区免费毛片| 中文在线观看免费www的网站| 亚洲av五月六月丁香网| 少妇被粗大猛烈的视频| 女人十人毛片免费观看3o分钟| 啦啦啦啦在线视频资源| 亚洲国产精品合色在线| 一个人观看的视频www高清免费观看| 国产成年人精品一区二区| 久久久精品欧美日韩精品| 在线观看美女被高潮喷水网站| 久久久久久国产a免费观看| 中国国产av一级| 精品久久久久久久末码| 日本撒尿小便嘘嘘汇集6| 亚洲国产精品国产精品| 搡老熟女国产l中国老女人| 悠悠久久av| 国内揄拍国产精品人妻在线| 男女做爰动态图高潮gif福利片| 综合色av麻豆| 日本精品一区二区三区蜜桃| 99九九线精品视频在线观看视频| videossex国产| 可以在线观看的亚洲视频| 中文字幕免费在线视频6| 国产精品一区二区免费欧美| 日本三级黄在线观看| 欧美+日韩+精品| 内射极品少妇av片p| av福利片在线观看| 婷婷精品国产亚洲av在线| 深夜a级毛片| 欧美另类亚洲清纯唯美| av在线天堂中文字幕| 国产一区二区三区在线臀色熟女| 高清毛片免费观看视频网站| 天堂影院成人在线观看| 一进一出抽搐动态| 国产一区二区三区在线臀色熟女| 精品免费久久久久久久清纯| 97在线视频观看| 18禁在线无遮挡免费观看视频 | 可以在线观看的亚洲视频| 国产单亲对白刺激| 一本精品99久久精品77| 久久人妻av系列| 免费一级毛片在线播放高清视频| 国产伦一二天堂av在线观看| 日韩国内少妇激情av| 99视频精品全部免费 在线| 亚洲av中文av极速乱| 无遮挡黄片免费观看| 婷婷色综合大香蕉| 国产一区二区在线观看日韩| 麻豆国产97在线/欧美| 欧美精品国产亚洲| 黑人高潮一二区| 久久久久久大精品| 美女xxoo啪啪120秒动态图| 午夜亚洲福利在线播放| 国产精品美女特级片免费视频播放器| 老师上课跳d突然被开到最大视频| 99热精品在线国产| 国产在线男女| 伊人久久精品亚洲午夜| 亚洲av成人精品一区久久| 国产色爽女视频免费观看| 亚洲中文日韩欧美视频| 亚洲第一电影网av| 丝袜喷水一区| 欧美高清成人免费视频www| 日韩国内少妇激情av| 国产激情偷乱视频一区二区| 国内精品一区二区在线观看| 精品一区二区三区视频在线观看免费| 婷婷六月久久综合丁香| 99在线人妻在线中文字幕| 69人妻影院| 欧美成人一区二区免费高清观看| 毛片女人毛片| 精品久久久久久久久久久久久| 国产伦一二天堂av在线观看| 波多野结衣高清无吗| 国产精品人妻久久久影院| 69人妻影院| 日本撒尿小便嘘嘘汇集6| 欧美最黄视频在线播放免费| 国产亚洲精品久久久久久毛片| 午夜福利18| 色哟哟·www| 最近在线观看免费完整版| 欧美成人免费av一区二区三区| 久久久久久久久久久丰满| 美女被艹到高潮喷水动态| 久久久久久久久中文| 少妇的逼水好多| 波多野结衣巨乳人妻| 三级经典国产精品| 日本色播在线视频| 久久久久久久午夜电影| 校园人妻丝袜中文字幕| 国产精品久久久久久av不卡| 99riav亚洲国产免费| 亚洲精品国产av成人精品 | .国产精品久久| 精品一区二区三区人妻视频| 国产av在哪里看| 免费不卡的大黄色大毛片视频在线观看 | 菩萨蛮人人尽说江南好唐韦庄 | 久久精品国产清高在天天线| 中文字幕精品亚洲无线码一区| 熟妇人妻久久中文字幕3abv| 色吧在线观看| 亚洲成a人片在线一区二区| 少妇熟女aⅴ在线视频| 国产黄色视频一区二区在线观看 | 99久久成人亚洲精品观看| 夜夜看夜夜爽夜夜摸| 亚洲精品粉嫩美女一区| 成人性生交大片免费视频hd| 国产精品一区二区三区四区免费观看 | 免费看美女性在线毛片视频| 久久久久久国产a免费观看| 老熟妇仑乱视频hdxx| 国产av在哪里看| 国产av不卡久久| 在现免费观看毛片| 成人一区二区视频在线观看| 国产精品综合久久久久久久免费| 久久人人爽人人爽人人片va| 麻豆成人午夜福利视频| 国产激情偷乱视频一区二区| 国产精品久久久久久亚洲av鲁大| or卡值多少钱| 免费看av在线观看网站| 一个人看视频在线观看www免费| 18禁黄网站禁片免费观看直播| 日日干狠狠操夜夜爽| 亚洲欧美精品综合久久99| 国产精品一区二区三区四区免费观看 | 久久久久久久午夜电影| 给我免费播放毛片高清在线观看| 晚上一个人看的免费电影| 日韩在线高清观看一区二区三区| 亚洲精品亚洲一区二区| 精品乱码久久久久久99久播| 校园人妻丝袜中文字幕| 春色校园在线视频观看| a级毛色黄片| 国产片特级美女逼逼视频| 香蕉av资源在线| 最近中文字幕高清免费大全6| 干丝袜人妻中文字幕| 伦精品一区二区三区| 悠悠久久av| 午夜a级毛片| 18禁在线播放成人免费| 成人性生交大片免费视频hd| 成人亚洲精品av一区二区| 波多野结衣巨乳人妻| 精品少妇黑人巨大在线播放 | 亚洲欧美日韩高清专用| 精品日产1卡2卡| 亚洲精华国产精华液的使用体验 | 97碰自拍视频| 国产男人的电影天堂91| 嫩草影院入口| a级毛色黄片| 啦啦啦观看免费观看视频高清| 国产一级毛片七仙女欲春2| 久久婷婷人人爽人人干人人爱| 免费大片18禁| 十八禁国产超污无遮挡网站| eeuss影院久久| 1024手机看黄色片| 国产成人freesex在线 | 色综合色国产| 床上黄色一级片| 精品午夜福利视频在线观看一区| 久久精品人妻少妇| 一本久久中文字幕| 亚洲av五月六月丁香网| 偷拍熟女少妇极品色| 又黄又爽又刺激的免费视频.| 日产精品乱码卡一卡2卡三| 一区二区三区免费毛片| 少妇熟女aⅴ在线视频| 亚洲熟妇熟女久久| 老女人水多毛片| 亚洲欧美日韩无卡精品| 亚洲成人久久爱视频| 婷婷精品国产亚洲av| 亚洲精品国产成人久久av| 色尼玛亚洲综合影院| 日韩精品青青久久久久久| 美女内射精品一级片tv| 国产亚洲精品综合一区在线观看| 色综合亚洲欧美另类图片| 97超级碰碰碰精品色视频在线观看| 精品不卡国产一区二区三区| 岛国在线免费视频观看| 尾随美女入室| 有码 亚洲区| 九九爱精品视频在线观看| 国产精品久久久久久亚洲av鲁大| 性色avwww在线观看| 亚洲精华国产精华液的使用体验 | 日本欧美国产在线视频| 国产高清不卡午夜福利| 丝袜美腿在线中文| 欧美绝顶高潮抽搐喷水| 乱人视频在线观看| a级一级毛片免费在线观看| 日本 av在线| 在线免费观看不下载黄p国产| 在线观看免费视频日本深夜| 免费人成视频x8x8入口观看| 91狼人影院| 久久人人爽人人爽人人片va| 十八禁国产超污无遮挡网站| 欧美日韩精品成人综合77777| 国产真实乱freesex| 亚洲av二区三区四区| 97在线视频观看| 亚洲天堂国产精品一区在线| 国产 一区精品| 亚洲av免费高清在线观看| 欧美激情久久久久久爽电影| 听说在线观看完整版免费高清| 久久久a久久爽久久v久久| 日韩中字成人| 干丝袜人妻中文字幕| 一区二区三区高清视频在线| 久久久色成人| 成年女人看的毛片在线观看| 亚洲五月天丁香| 91狼人影院| 亚洲内射少妇av| 亚洲久久久久久中文字幕| 亚洲真实伦在线观看| 国产亚洲av嫩草精品影院| 久久久久国产网址| 精品免费久久久久久久清纯| 亚洲,欧美,日韩| 国产国拍精品亚洲av在线观看| 欧美国产日韩亚洲一区| 日韩精品有码人妻一区| 色av中文字幕| 美女免费视频网站| 啦啦啦啦在线视频资源| 国产三级在线视频| 中文字幕精品亚洲无线码一区| 亚洲中文字幕一区二区三区有码在线看| 91久久精品国产一区二区成人| 99久久精品国产国产毛片| 国产精品伦人一区二区| 亚洲人成网站在线播放欧美日韩| 床上黄色一级片| 国产精品一二三区在线看| 日韩在线高清观看一区二区三区| 最新中文字幕久久久久| 最近手机中文字幕大全| 日本一本二区三区精品| 精品熟女少妇av免费看| 97在线视频观看| 在线看三级毛片| a级一级毛片免费在线观看| 亚洲真实伦在线观看| 毛片一级片免费看久久久久| 成熟少妇高潮喷水视频| 成年版毛片免费区| 日本 av在线| 国产亚洲av嫩草精品影院| 亚洲人成网站在线观看播放| 自拍偷自拍亚洲精品老妇| 亚洲最大成人av| 美女高潮的动态| 免费av不卡在线播放| 亚洲av成人av| 日韩亚洲欧美综合| 观看免费一级毛片| 欧美一区二区精品小视频在线| 色哟哟·www| 久久99热6这里只有精品| 日本三级黄在线观看| 午夜福利在线观看免费完整高清在 | 特级一级黄色大片| 亚洲美女视频黄频| 亚洲欧美日韩高清专用| 亚洲欧美成人精品一区二区| 日产精品乱码卡一卡2卡三| 欧美激情在线99| 十八禁国产超污无遮挡网站| 亚洲激情五月婷婷啪啪| 黄色视频,在线免费观看| 老司机福利观看| 亚洲中文字幕一区二区三区有码在线看| 黑人高潮一二区| 精品午夜福利视频在线观看一区| 久久精品91蜜桃| 一级毛片久久久久久久久女| av在线亚洲专区| 中文字幕熟女人妻在线| 免费av观看视频| 国产一区二区在线av高清观看| 亚洲在线自拍视频| 精品午夜福利在线看| 国产色爽女视频免费观看| 久久久久久伊人网av| 亚洲图色成人| 国产成人91sexporn| 亚洲国产精品久久男人天堂| 免费av毛片视频| 亚洲美女搞黄在线观看 | 国产色爽女视频免费观看| 99热网站在线观看| 老女人水多毛片| 高清日韩中文字幕在线| 男女那种视频在线观看| 天堂√8在线中文| 天堂网av新在线| 黑人高潮一二区| 国产精品一区二区免费欧美| 五月玫瑰六月丁香| 国产欧美日韩精品一区二区| 亚洲无线在线观看| 亚洲欧美成人精品一区二区| 一级毛片久久久久久久久女| 人妻制服诱惑在线中文字幕| 91久久精品国产一区二区成人| 又黄又爽又免费观看的视频| 精品久久久久久久末码| 成人特级黄色片久久久久久久| 中国美女看黄片| 欧美最新免费一区二区三区| 春色校园在线视频观看| 国产高潮美女av| 国产精品一区www在线观看| 1000部很黄的大片| 国产麻豆成人av免费视频| 国内少妇人妻偷人精品xxx网站| 熟女人妻精品中文字幕| 在线观看av片永久免费下载| 乱系列少妇在线播放| 在线观看av片永久免费下载| 99热这里只有是精品在线观看| 国产av在哪里看| 麻豆av噜噜一区二区三区| 国产三级在线视频| 成熟少妇高潮喷水视频| 国产成人91sexporn| 中文字幕人妻熟人妻熟丝袜美| 国产成人91sexporn| 一本精品99久久精品77| 久久精品影院6| 国产精品野战在线观看| or卡值多少钱| 国产伦一二天堂av在线观看| 亚洲aⅴ乱码一区二区在线播放| 少妇熟女aⅴ在线视频| 女人十人毛片免费观看3o分钟| 99久久九九国产精品国产免费| 免费人成视频x8x8入口观看| 中文亚洲av片在线观看爽| 午夜福利视频1000在线观看| 22中文网久久字幕| 久久精品国产亚洲网站| 亚洲成人中文字幕在线播放| 亚洲国产精品国产精品| 97超视频在线观看视频| 国内精品久久久久精免费| 久久人人爽人人爽人人片va| 国产精品人妻久久久久久| 国产精品女同一区二区软件| 亚洲色图av天堂| 欧美成人一区二区免费高清观看| 国产一级毛片七仙女欲春2| 亚洲国产色片| 午夜影院日韩av| 欧美成人精品欧美一级黄| 午夜a级毛片| 天堂影院成人在线观看| 床上黄色一级片| 久久久久久久久中文| 一级毛片久久久久久久久女| 国产黄片美女视频| 99久国产av精品国产电影| 一进一出抽搐gif免费好疼| 最近2019中文字幕mv第一页| 亚洲乱码一区二区免费版| 晚上一个人看的免费电影| 国产精品av视频在线免费观看| 久久久久精品国产欧美久久久| 亚洲av免费在线观看| 啦啦啦韩国在线观看视频| 91久久精品国产一区二区三区| 伦精品一区二区三区| 亚洲国产精品成人综合色| 在线观看免费视频日本深夜| 国产精品一区www在线观看| 日产精品乱码卡一卡2卡三| 91精品国产九色| 久久99热这里只有精品18| 久久久a久久爽久久v久久| 国产黄a三级三级三级人| 午夜视频国产福利| 亚洲七黄色美女视频| 少妇熟女欧美另类| 蜜臀久久99精品久久宅男| 久久草成人影院| 国产精品av视频在线免费观看| 真实男女啪啪啪动态图| 久久久精品94久久精品| 精品久久久久久久久久久久久| 亚洲精品色激情综合| 日韩一区二区视频免费看| 美女xxoo啪啪120秒动态图| 大香蕉久久网| 国产成人影院久久av| 日韩欧美 国产精品| 麻豆精品久久久久久蜜桃| 2021天堂中文幕一二区在线观| 欧美成人精品欧美一级黄| 亚洲综合色惰| 国产精品野战在线观看| а√天堂www在线а√下载| 三级男女做爰猛烈吃奶摸视频| 国产亚洲精品久久久com| 91午夜精品亚洲一区二区三区| 国产69精品久久久久777片| 男人舔女人下体高潮全视频| 亚洲在线观看片| 亚洲最大成人av| 国产毛片a区久久久久| 美女cb高潮喷水在线观看| 男女啪啪激烈高潮av片| 亚洲av电影不卡..在线观看| 黑人高潮一二区| 18+在线观看网站| av在线播放精品| 国产亚洲精品久久久久久毛片| 精品人妻熟女av久视频| 欧美日韩精品成人综合77777| 亚洲天堂国产精品一区在线| 九九热线精品视视频播放| 国产成人freesex在线 | 免费看a级黄色片| 亚洲av电影不卡..在线观看| 国产高清视频在线观看网站| 国产伦在线观看视频一区| 久久天躁狠狠躁夜夜2o2o| 成人av一区二区三区在线看| 久久草成人影院| 国产精品,欧美在线| 赤兔流量卡办理| 两个人视频免费观看高清| 欧美三级亚洲精品| 麻豆精品久久久久久蜜桃| 国产精品av视频在线免费观看| 国产探花在线观看一区二区| 超碰av人人做人人爽久久| 老熟妇乱子伦视频在线观看| 欧美色视频一区免费| 国产男靠女视频免费网站| 99热这里只有精品一区| 精品久久久久久久久av| 日韩精品中文字幕看吧| av女优亚洲男人天堂| 少妇人妻一区二区三区视频| 国产精品一区二区免费欧美| 亚洲熟妇熟女久久| 看片在线看免费视频| 激情 狠狠 欧美| av在线亚洲专区| av在线天堂中文字幕| 欧美人与善性xxx| 精品久久国产蜜桃| 亚洲欧美日韩高清在线视频| 欧美bdsm另类| 成人二区视频| av中文乱码字幕在线| 亚洲成a人片在线一区二区| 99久久久亚洲精品蜜臀av| 成人性生交大片免费视频hd| 国产高潮美女av| 熟女人妻精品中文字幕| 亚洲精品亚洲一区二区| 国产日本99.免费观看| 国产午夜精品久久久久久一区二区三区 | 免费看av在线观看网站| 午夜福利18| 91精品国产九色| 少妇被粗大猛烈的视频| 校园春色视频在线观看| 久久婷婷人人爽人人干人人爱| 久久精品国产亚洲av天美| 丰满的人妻完整版| 久久人妻av系列| 亚洲国产欧洲综合997久久,| 国产精品野战在线观看| 我要看日韩黄色一级片| 日日摸夜夜添夜夜添av毛片| 精品免费久久久久久久清纯| 看十八女毛片水多多多| videossex国产| 免费观看在线日韩| 麻豆成人午夜福利视频| 国产三级中文精品| a级毛色黄片| 精品久久久久久久久亚洲| 别揉我奶头 嗯啊视频| 亚洲av免费在线观看| 99精品在免费线老司机午夜| 亚洲精品国产成人久久av| 欧美激情国产日韩精品一区| 卡戴珊不雅视频在线播放| 变态另类成人亚洲欧美熟女| 国产亚洲精品久久久com| 一区二区三区高清视频在线| 一级黄片播放器| 久久久久国产网址| 国产精品一及| 亚洲四区av| 神马国产精品三级电影在线观看| 特大巨黑吊av在线直播| 精品乱码久久久久久99久播| 成人精品一区二区免费| 午夜亚洲福利在线播放| 级片在线观看| 日韩欧美三级三区| 日韩欧美在线乱码| 国产高清有码在线观看视频| 国产精品久久久久久久电影| 乱系列少妇在线播放| 亚洲美女黄片视频| 人妻久久中文字幕网| 在线免费观看的www视频| 校园春色视频在线观看| 两个人的视频大全免费| 成人性生交大片免费视频hd| 日本色播在线视频| 欧美3d第一页| 我的女老师完整版在线观看| 日日摸夜夜添夜夜添小说| 久久久精品欧美日韩精品| 又黄又爽又免费观看的视频| 一区二区三区免费毛片| 国产精品久久久久久久电影| 国产美女午夜福利| 欧美bdsm另类| 精品国内亚洲2022精品成人| 超碰av人人做人人爽久久| 人妻制服诱惑在线中文字幕| 欧美性猛交黑人性爽| 日日摸夜夜添夜夜添av毛片| 国产高清有码在线观看视频| 三级男女做爰猛烈吃奶摸视频| 久久午夜亚洲精品久久| 国产三级中文精品| 免费看日本二区| 亚洲欧美成人综合另类久久久 | 国产又黄又爽又无遮挡在线| 九九久久精品国产亚洲av麻豆| 国产又黄又爽又无遮挡在线| 长腿黑丝高跟| 午夜日韩欧美国产| 午夜亚洲福利在线播放| 欧美高清成人免费视频www| 黄色视频,在线免费观看| 亚洲av五月六月丁香网| 午夜免费激情av| 一区二区三区高清视频在线| 欧美丝袜亚洲另类| 日韩中字成人| 亚洲人成网站高清观看| 亚洲性夜色夜夜综合| 国语自产精品视频在线第100页| 亚洲欧美日韩高清专用| 午夜影院日韩av| 精品久久久久久久久久久久久| 国产精品三级大全| 亚洲欧美日韩东京热| 插阴视频在线观看视频| 男女啪啪激烈高潮av片|